Clinical Trial Update: Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating actual human use of subcutaneous methotrexate delivered via the VIBEX MTX Auto-Injector for rheumatoid arthritis; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Antares Pharma Inc. | Conditions: Rheumatoid Arthritis (RA) | Phase 2 | Status: COMPLETED | Results posted: 2014-04-30